Genotype influences end-stage heart failure occurrence in dilated cardiomyopathy

被引：0
|
作者：
Cannie, D. [1 ,2 ]
Bakalakos, A. [1 ,2 ]
Protonotarios, A. [1 ,2 ]
Syrris, P. [1 ]
Lorenzini, M. [1 ,2 ]
Guttmann, O. [1 ,2 ]
O'mahony, C. [1 ,2 ]
Savvatis, K. [1 ,2 ]
Lopes, L. [1 ,2 ]
Sekhri, N. [2 ]
Mohiddin, S. [2 ]
Elliott, P. [1 ,2 ]
机构：
[1] UCL, London, England
[2] Barts Heart Ctr, London, England
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Myocardial capillary density is severely reduced in patients with end-stage congestive heart failure secondary to idiopathic dilated cardiomyopathy
    Tsagalou, E.
    Agapitos, E.
    Kanakakis, J.
    Alexopoulos, G.
    Ntalianis, A.
    Lazaris, N.
    Pantsios, C.
    Nanas, J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A308 - A308
  • [22] Tranilast, Transient Receptor Potential Vanilloid 2 Antagonist, Ameliorates End-Stage Heart Failure of Mice With Dilated Cardiomyopathy
    Iwata, Yuko
    Komamura, Kazuo
    CIRCULATION, 2014, 130
  • [23] Tranilast, Orally Active TRPV2 Antagonist, Ameliorates End-stage Heart Failure in Mice with Dilated Cardiomyopathy
    Komamura, Kazuo
    Iwata, Yuko
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S198 - S199
  • [24] Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
    Sushma Reddy
    Alan Fung
    Cedric Manlhiot
    Elif Seda Selamet Tierney
    Wendy K. Chung
    Elizabeth Blume
    Beth D. Kaufman
    Elizabeth Goldmuntz
    Steven Colan
    Seema Mital
    Pediatric Research, 2015, 77 : 363 - 369
  • [25] Improved early outcome for end-stage dilated cardiomyopathy in children
    McMahon, AM
    van Doorn, C
    Burch, M
    Whitmore, P
    Neligan, S
    Rees, P
    Radley-Smith, R
    Goldman, A
    Brown, K
    Cohen, G
    Tsang, V
    Elliott, M
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (06): : 1781 - 1787
  • [26] Partial left ventriculectomy in pediatric end-stage dilated cardiomyopathy
    Shinpei Yoshii
    Shoji Suzuki
    Shigeru Hosaka
    Hiroshi Osawa
    Wataru Takahashi
    Samuel JK Abraham
    Yusuke Tada
    Hisashi Sugiyama
    Tetsushi Tan
    Hiroshi Kanazawa
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 2002, 50 (6): : 235 - 240
  • [27] Study an microbial persistence in end-stage idiopathic dilated cardiomyopathy
    de Leeuw, N
    Melchers, WJG
    Balk, AHMM
    de Jonge, N
    Galama, JMD
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) : 522 - 525
  • [28] Partial left ventriculectomy for the treatment of end-stage dilated cardiomyopathy
    Huang, FJ
    Zhang, JQ
    Yang, JF
    Bo, P
    You, B
    Cao, XR
    Han, J
    Huang, GH
    Xu, CL
    Wu, Q
    Chen, YC
    CHINESE MEDICAL JOURNAL, 1999, 112 (11) : 1001 - 1004
  • [29] Levosimendan in End-Stage Heart Failure
    Yeo, Poh Shuan Daniel
    JACC-HEART FAILURE, 2013, 1 (04) : 365 - 365
  • [30] ICDs in end-stage heart failure
    Pettit, Stephen J.
    Browne, Susan
    Hogg, Karen J.
    Connelly, Derek T.
    Gardner, Roy S.
    May, Carl R.
    Macleod, Una
    Mair, Frances S.
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2012, 2 (02) : 94 - 97
12345